Scholarlink

<p>To evaluate the therapeutic efficacy and safety of stereotactic radiosurgery (SRS) in the management of large cystic brain metastases. A retrospective analysis was conducted. Large cystic brain metastases were defined as cyst volume ≥ 5 mL. Tumors that received SRS as adjuvant therapy following surgery were excluded. The cohort was stratified into two groups: (1) SRS group (upfront hypofractionated SRS without Ommaya reservoir [OR]), (2) OR-SRS group (cyst aspiration via OR before SRS). Local tumor control rate (LCR), progression-free survival (PFS), overall survival (OS), and radiation-induced adverse events (RAEs) were evaluated. Thirty-one metastases in 28 patients met the inclusion criteria: SRS (14 metastases) and OR-SRS (17 metastases). Most baseline characteristics, including cyst diameter (<i>P</i> = 0.15), cyst volume (<i>P</i> = 0.06), and tumor volume (<i>P</i> = 0.95), were not significantly different between the groups. The cyst volume just before SRS in the OR-SRS group was significantly smaller compared to the SRS group (<i>P</i> &lt; 0.01; Mann-Whitney U test). The LCR was 86% in the SRS group and 82% OR-SRS group (<i>P</i> = 1.00). Other outcomes, including PFS, RAEs, and OS, were not significantly different between the groups. Kaplan-Meier analysis revealed no statistically significant differences in PFS or OS among the groups (<i>P</i> = 0.28 and <i>P</i> = 0.20, respectively; log-rank test). This study demonstrates that both SRS and OR-SRS are effective and safe treatment modalities for large cystic brain metastases. The treatment outcomes were comparable, and these approaches may be equally viable options in the management of this challenging subset.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Efficacy and safety of stereotactic radiosurgery for large cystic brain metastases: a comparison with and without cyst aspiration via Ommaya reservoir

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月23日

查看全文
  • Sukwoo Hong,
  • Sheriff Adam,
  • Hirokazu Takami,
  • Motoyuki Umekawa,
  • Yuki Shinya,
  • Hirotaka Hasegawa,
  • Mariko Kawashima,
  • Yousuke Kitagawa,
  • Masashi Nomura,
  • Shunsaku Takayanagi,
  • Nobuhito Saito

摘要

To evaluate the therapeutic efficacy and safety of stereotactic radiosurgery (SRS) in the management of large cystic brain metastases. A retrospective analysis was conducted. Large cystic brain metastases were defined as cyst volume ≥ 5 mL. Tumors that received SRS as adjuvant therapy following surgery were excluded. The cohort was stratified into two groups: (1) SRS group (upfront hypofractionated SRS without Ommaya reservoir [OR]), (2) OR-SRS group (cyst aspiration via OR before SRS). Local tumor control rate (LCR), progression-free survival (PFS), overall survival (OS), and radiation-induced adverse events (RAEs) were evaluated. Thirty-one metastases in 28 patients met the inclusion criteria: SRS (14 metastases) and OR-SRS (17 metastases). Most baseline characteristics, including cyst diameter (P = 0.15), cyst volume (P = 0.06), and tumor volume (P = 0.95), were not significantly different between the groups. The cyst volume just before SRS in the OR-SRS group was significantly smaller compared to the SRS group (P < 0.01; Mann-Whitney U test). The LCR was 86% in the SRS group and 82% OR-SRS group (P = 1.00). Other outcomes, including PFS, RAEs, and OS, were not significantly different between the groups. Kaplan-Meier analysis revealed no statistically significant differences in PFS or OS among the groups (P = 0.28 and P = 0.20, respectively; log-rank test). This study demonstrates that both SRS and OR-SRS are effective and safe treatment modalities for large cystic brain metastases. The treatment outcomes were comparable, and these approaches may be equally viable options in the management of this challenging subset.